Purple Biotech (PPBT) Current Leases (2019 - 2026)

Purple Biotech (PPBT) reported Current Leases of $184000.0 for Q1 2026, down 24.59% on a QoQ basis from $244000.0 in Q4 2025.

Purple Biotech (PPBT) has 8 years of Current Leases data on file, last reported at $184000.0 in Q1 2026.

  • Quarterly Current Leases changed N/A year-over-year to $184000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184000.0 (changed N/A YoY) and the FY2025 annual result came in at $244000.0, up 33.33% from the prior year.
  • Current Leases slipped to $184000.0 in Q1 2026 per PPBT's latest filing, from $244000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $244000.0 in Q4 2025 and bottomed at $183000.0 in Q4 2024.
  • The 5-year median for Current Leases is $188000.0 (2023), against an average of $198600.0.
  • The widest annual swing landed in 2023, when Current Leases retreated 3.09%; it then jumped 33.33% in 2025.
  • Tracing PPBT's Current Leases over 5 years: stood at $194000.0 in 2022, then dropped by 3.09% to $188000.0 in 2023, then fell by 2.66% to $183000.0 in 2024, then jumped by 33.33% to $244000.0 in 2025, then decreased by 24.59% to $184000.0 in 2026.
  • Per Business Quant, the three latest PPBT Current Leases figures stand at $184000.0 (Q1 2026), $244000.0 (Q4 2025), and $183000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Purple Biotech 3.58 Bn 3.57 Bn - 184,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 184,000.00
Dec 31, 2025 244,000.00
Sep 30, 2025 207,000.00
Jun 30, 2025 103,000.00
Mar 31, 2025 137,000.00
Dec 31, 2024 183,000.00
Sep 30, 2024 184,000.00
Jun 30, 2024 182,000.00
Mar 31, 2024 186,000.00
Dec 31, 2023 188,000.00
Sep 30, 2023 178,000.00
Jun 30, 2023 184,000.00
Mar 31, 2023 189,000.00
Dec 31, 2022 194,000.00
Sep 30, 2022 193,000.00
Jun 30, 2022 195,000.00
Mar 31, 2022 199,000.00
Dec 31, 2021 199,000.00
Sep 30, 2021 199,000.00
Jun 30, 2021 199,000.00
Mar 31, 2021 207,000.00
Dec 31, 2020 207,000.00
Jun 30, 2020 109,000.00
Dec 31, 2019 195,000.00
Jun 30, 2019 194,000.00